These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31712222)

  • 1. PTEN in Regulating Hematopoiesis and Leukemogenesis.
    Wu Y; Zhu H; Wu H
    Cold Spring Harb Perspect Med; 2020 Oct; 10(10):. PubMed ID: 31712222
    [No Abstract]   [Full Text] [Related]  

  • 2. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.
    Kalaitzidis D; Sykes SM; Wang Z; Punt N; Tang Y; Ragu C; Sinha AU; Lane SW; Souza AL; Clish CB; Anastasiou D; Gilliland DG; Scadden DT; Guertin DA; Armstrong SA
    Cell Stem Cell; 2012 Sep; 11(3):429-39. PubMed ID: 22958934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.
    Magee JA; Ikenoue T; Nakada D; Lee JY; Guan KL; Morrison SJ
    Cell Stem Cell; 2012 Sep; 11(3):415-28. PubMed ID: 22958933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PI3K p110β-Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis.
    Yuzugullu H; Baitsch L; Von T; Steiner A; Tong H; Ni J; Clayton LK; Bronson R; Roberts TM; Gritsman K; Zhao JJ
    Nat Commun; 2015 Oct; 6():8501. PubMed ID: 26442967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN and leukemia stem cells.
    Fragoso R; Barata JT
    Adv Biol Regul; 2014 Sep; 56():22-9. PubMed ID: 24961634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Stem Cell Activity Is Regulated by Pten Phosphorylation Through a Niche-Dependent Mechanism.
    Li J; Zhang J; Tang M; Xin J; Xu Y; Volk A; Hao C; Hu C; Sun J; Wei W; Cao Q; Breslin P; Zhang J
    Stem Cells; 2016 Aug; 34(8):2130-44. PubMed ID: 27096933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion.
    Lee JY; Nakada D; Yilmaz OH; Tothova Z; Joseph NM; Lim MS; Gilliland DG; Morrison SJ
    Cell Stem Cell; 2010 Nov; 7(5):593-605. PubMed ID: 21040901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of Pten in the balance between proliferation and differentiation of hematopoietic stem cells in zebrafish.
    Choorapoikayil S; Kers R; Herbomel P; Kissa K; den Hertog J
    Blood; 2014 Jan; 123(2):184-90. PubMed ID: 24124088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN in the haematopoietic system and its therapeutic indications.
    Cheung AM; Mak TW
    Trends Mol Med; 2006 Nov; 12(11):503-5. PubMed ID: 16996801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Autophagy in Normal and Malignant Hematopoiesis.
    Koschade SE; Brandts CH
    J Mol Biol; 2020 Jan; 432(1):261-282. PubMed ID: 31260695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization.
    Tesio M; Oser GM; Baccelli I; Blanco-Bose W; Wu H; Göthert JR; Kogan SC; Trumpp A
    J Exp Med; 2013 Oct; 210(11):2337-49. PubMed ID: 24127490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
    Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
    Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.
    Perry JM; He XC; Sugimura R; Grindley JC; Haug JS; Ding S; Li L
    Genes Dev; 2011 Sep; 25(18):1928-42. PubMed ID: 21890648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of early leukemia and lymphoma.
    Zhao XF; Reitz M; Chen QC; Stass S
    Cancer Biomark; 2010; 9(1-6):341-74. PubMed ID: 22112484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.
    Zhang J; Grindley JC; Yin T; Jayasinghe S; He XC; Ross JT; Haug JS; Rupp D; Porter-Westpfahl KS; Wiedemann LM; Wu H; Li L
    Nature; 2006 May; 441(7092):518-22. PubMed ID: 16633340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeobox genes in hematopoiesis and leukemogenesis.
    Shimamoto T; Ohyashiki K; Toyama K; Takeshita K
    Int J Hematol; 1998 Jun; 67(4):339-50. PubMed ID: 9695407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells.
    You D; Xin J; Volk A; Wei W; Schmidt R; Scurti G; Nand S; Breuer EK; Kuo PC; Breslin P; Kini AR; Nishimura MI; Zeleznik-Le NJ; Zhang J
    Cell Rep; 2015 Mar; 10(12):2055-68. PubMed ID: 25801032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
    Wang X; Huang H; Young KH
    Aging (Albany NY); 2015 Dec; 7(12):1032-49. PubMed ID: 26655726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy and Metabolism in Normal and Malignant Hematopoiesis.
    Stergiou IE; Kapsogeorgou EK
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivo.
    Wan X; Liu L; Zhou P; Hui X; He Q; Yu F; Zhang W; Ding X; Yuan X; Zhang N; Zhao Y; Zhu R; Liu Y; Hao P; Auwerx J; Song X; Leng Q; Zhang Y
    Blood Adv; 2019 Feb; 3(4):644-657. PubMed ID: 30804018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.